Ligand Pharm
(LGND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 10,892 | 11,420 | -527 | 9,715 | -10,373 |
| Depreciation Amortization | 6,351 | 2,663 | 2,727 | 1,088 | 510 |
| Income taxes - deferred | 410 | 374 | -1,204 | -13,402 | N/A |
| Accounts receivable | -10,412 | 2,367 | 1,521 | -3,915 | -375 |
| Other Working Capital | -10,949 | -702 | -2,768 | -5,875 | -24,738 |
| Other Operating Activity | 24,274 | 4,568 | 412 | 11,217 | 7,909 |
| Operating Cash Flow | $20,566 | $20,690 | $161 | $-1,172 | $-27,067 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,342 | 0 | 10,000 | 9,346 | 18,456 |
| PPE Investments | -6 | -377 | -575 | 452 | 519 |
| Net Acquisitions | N/A | N/A | N/A | -32,024 | -2,834 |
| Purchase Sale Intangibles | -1,000 | -3,571 | N/A | N/A | -1,247 |
| Other Investing Activity | -4,363 | -4,597 | -8,162 | -2,906 | -1,601 |
| Investing Cash Flow | $-2,027 | $-4,974 | $1,263 | $-25,132 | $14,540 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 245,000 | 0 | 7,500 | 30,000 | N/A |
| Debt Repayment | -9,366 | -19,586 | -10,000 | 0 | -91 |
| Common Stock Issued | 16,199 | 3,128 | 6,416 | 54 | 23 |
| Common Stock Repurchased | -67,954 | 0 | 0 | -55 | -91 |
| Other Financing Activity | -53,854 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $130,025 | $-16,458 | $3,916 | $29,999 | $-159 |
| Beginning Cash Position | 11,639 | 12,381 | 7,041 | 3,346 | 16,032 |
| End Cash Position | 160,203 | 11,639 | 12,381 | 7,041 | 3,346 |
| Net Cash Flow | $148,564 | $-742 | $5,340 | $3,695 | $-12,686 |
| Free Cash Flow | |||||
| Operating Cash Flow | 20,566 | 20,690 | 161 | -1,172 | -27,067 |
| Capital Expenditure | -6 | -377 | -595 | -78 | -70 |
| Free Cash Flow | 20,560 | 20,313 | -434 | -1,250 | -27,137 |